Patent · US Expired

Imidazodiazepine derivatives

US5387585A · kind A · utility

40Cited by

3References

39Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Rene Borer · Reinach, CH
Walter Gassner · Bottmingen, CH
Max Gerecke · Reinach, CH
Emilio Kyburz · Reinach, CH

Key dates

Filing date	Nov 15, 1993
Grant date	Feb 7, 1995
Priority date	—
Expiry date	Nov 15, 2013

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The novel imidazodiazepine derivatives of the formula: ##STR1## wherein the substituents are as described in the specification, can be used for the control or prevention of epileptic seizures, anxiety, tension and excitation states, sleep disorders, schizophrenic symptoms, hepatic encephalopathy and senile dementia, as well as, in the partial or complete antagonization of undesired side-effects of substances acting on benzodiazepine receptors after over-dosage or after their use in intensive medicine and in anesthesia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.